|
|
|
|
|
|
|
4
|
|
Sector
|
Education And Research Institute Tenders
|
Tender Value
|
 5 Lakh
|
|
Location
|
Jharkhand Tenders
|
Ref.No
|
71605663
|
|
Closing Date
|
20 - May - 2024
|
18 Days to go
|
View Tender Details
|
|
Supply of Inj Avil 45 5mg 2ml, Inj Adenosine 3 Mg 1 Ml, Inj Atracurium 10mg 1ml, Inj Amikacin 500 Mg, Inj Atropine 6 Mg 1 Ml, Inj Adrenaline 1 Mg 1ml, Inj Amioderone 150 Mg 3 Ml, Inj Ceftriaxone 1 Gm, 1 5 Gm, Inj Ceftriaxone and Salbactum 1 5 Mg, Inj Cistracurium 20mg 10 Ml, Inj Lasix 20 Mg 2 Ml, Inj Pantop 40 Mg, Inj Lignocain 2 Percent, Inj Metrogyl 500 Mg, Inj Piperacillin and Tazobactam, Inj Ntg 5 Mg 5 Ml, Inj Meropenam 1 Gm, Inj Linezolid 600 Mg, Inj Imipenam Inj Cilastin 500 Mg 1 Gm, Inj Vecuronium 10mg, Inj Succinyl Choline Chloride 50 Mg, Inj Isoprenaline 2 Mg, Inj Milirinone 1 Mg 1ml, Inj Tramadol, Inj Rocuronium, Inj Ketamine, Inj Hydrocort, Inj Thiopentone Sodium, Inj Dexmedetomidine, Inj N Acetyl Cysteine, Inj Polymixine B, Inj Colistine, Inj Tetracycline, Inj Dexamethasone, Inj Labetelol, Inj Dopamine, Inj Dobutamine, Inj Sodabicarb, Inj Kcl, Inj Perinorm, Inj Emset, Inj Heparine, Inj Deriphylline, Inj Pcm, Inj Propofol, Inj Phetanyl, Inj Midazolam, Inj Diltizem, Inj Calcium Gluconate, Inj Nor Epinephrine, Inj Phenytoin, Inj Mgs04, Ns 0 9per Cent, 3 Percent Ns, Rl, Dns, 5 Percent Dextrose, 10 Percent Dextrose, D25 Percent, Isolate P, Isolate M, Haemocel, Mannitol, 0 45 Percent Ns, Distilled Water, Diclofenac Aq, Etomidate, Glycopyrrolate, Myo Pyrolate, Ropivacaine 0 2 Percent, 0 5 Percent, 0 75 Per Cent, , Ropivacaine, Bupivacaine, Esmolol, Metropolol, Sodium Nitroprusside, Slbutamol Respules, Budecort Respoules, Albuterol Respoules, Levoline Respoules, Nicardipine, Buprenorphine Patch, Human Albumin, H Insulin, Inj Enoxaparine, Protamine Sulphate, Tranexamic Acid, Torsemide, Lorazepam, Inj Vitamin K, Inj Thiamine, Inj Meropenum, Inj Epidrine, Inj Phenytion, Inj Gentamycin, Inj Fluconazole, Inj Ciprofloxine, Basal Insulin, Iv Set, Pmo Line, Bt Set - Icu Medicine Qty : 16850
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|